摘要结核病患者普遍存在免疫功能异常，机体的免疫状态和结核病的发生、发展和转归密切相关。目前临床医生对结核病的免疫治疗认识明显不足。为推动我国结核病免疫治疗新方法的应用，最大程度使结核病患者获益，中华医学会结核病学分会制定《结核病免疫治疗专家共识（2022年版）》。本共识对结核病的免疫学发病机制、免疫治疗适宜人群和免疫治疗目的分别进行了阐述，并对常用免疫治疗制剂的应用提出了推荐意见（引用证据），对其使用方法、不良反应和注意事项分别说明，以期为临床医生进行结核病免疫治疗提供参考。

abstractsPatients with tuberculosis(TB) usually have abnormal immune function, and the host immunological status is closely related to the occurrence, development and outcome of TB. At present, the knowledge of immunotherapy of TB is obviously insufficient. In order to promote the application of new methods of TB immunotherapy in China and achieve the maximum possible gain of TB patients, the Chinese Society of Tuberculosis/Chinese Medical Association issued the Expert Consensus on TB Immunotherapy (2022 edition). This consensus described the immunological pathogenesis of TB, appropriate patients and goals of immunotherapy. Recommendations (reference evidence) on the application of immunotherapeutic preparations were put forward, with a description of the method of application, adverse reactions and precautions, so as to provide reference for clinical doctors for TB immunotherapy.